TriSalus Life Sciences (TLSI) SEC filings
TriSalus Life Sciences (TLSI) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported TLSI revenue for 2025-12-31 was $45.2M. Net income was -$39.2M. Revenue was up 53.4% from 2024-12-31 to 2025-12-31. TLSI currently screens at market cap $143.1M. The TLSI filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what TriSalus Life Sciences said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for TLSI — what management said, what changed, and why it matters.
No cached SEC filings for TLSI yet. When an 8-K lands, this page will list it.
These filings as JSON? API free 100/dayTLSI SEC filings FAQ
What events are listed on the TLSI SEC page?
Cached event headlines on this TriSalus Life Sciences (TLSI) SEC page: "TLSI earnings". Events: https://lician.com/sec/tlsi
What are TLSI's latest revenue and net income?
Latest cached TriSalus Life Sciences (TLSI) revenue for Dec 31, 2025 was $45.2M. Net income was -$39.2M. Statements: https://lician.com/financials/tlsi